Description
Unlocking deeper data inside liver cellular dynamics and gastrointestinal pathways has led modern laboratories to focus heavily on how specific short-chain biomolecules target hepatic homeostasis. The Ovagen peptide operates as a highly strategic molecular tool, driving straight into hepatocyte protection and balancing digestive tissue function.
Core Research Focus
Hepatic Bio-Regulation: Helps specialists examine how synthetic tripeptide structures protect hepatocytes and reinforce deep liver cellular profiles.
Digestive Cellular Longevity: Enables modern laboratories to gain crucial data on gastrointestinal tissue preservation, liver cell adaptation, and cellular recovery habits using pure Ovagen peptide.
Comparative Bioregulator Research: To evaluate hepatic tripeptide models alongside short-chain chromatin-activating bioregulators, explore our Livagen Research Peptide. You can also review our laboratory quality standards on our About Us Page.
Technical Specifications
| Specification | Details |
| Primary Target | Hepatic / Liver Cell Bio-Regulator |
| Sequence | Glu-Asp-Leu (Synthetic Tripeptide) |
| Documentation | COA verified peptides status included |
| Category | Hepatic & Digestive Peptides & Peptide Bioregulators |
| Format | Sterile Lyophilized Powder |
Handling & Storage Guidelines
Storage Condition: Lock the dry vial away in deep freeze storage at -20°C for long-term stability, protected from direct light exposure.
Reconstitution & Handling: Reconstitute gently by running liquid media down the inside vial wall to preserve structural integrity. For indexed literature and PubMed research on liver peptide bioregulation, consult PubMed Ovagen Research.
Usage Safety: Protect from sharp temperature shifts post-reconstitution and avoid multiple freeze-thaw cycles to keep the setup stable.
Research Disclaimer: This compound is synthesized strictly for laboratory research and development purposes. It is not intended for human therapeutic, diagnostic, or clinical use.





Reviews
There are no reviews yet.